Monthly Archives: January 2016

USAID announces new partnerships to combat MDR-TB at White House plan launch

By on .

At last week’s launch of the National Action Plan for Combating Multidrug-Resistant Tuberculosis, the U.S. Agency for International Development announced expanded partnerships with Janssen, the maker of bedaquiline, the first tuberculosis drug to be produced since the 1950s, and Cepheid, maker of the GeneXpert rapid diagnostic test for drug-resistant tuberculosis. Janssen, the pharmaceutical branch of […]

MDR-TB national action plan raises questions on targets and funding

By on .

After waiting months for the White House’s release of the National Action Plan for Combating Multidrug-Resistant Tuberculosis, TB advocates are asking why the plan isn’t more ambitious (considering some of the plan’s milestones are already close to being reached), and whether the Obama Administration will propose enough funding to put the plan into action. The alternative, they […]

A clean needle, an HIV test, and acknowledgment . . . We’re reading about simple solutions, out of reach

By on .

HIV and STI Testing and Treatment Policies – Mandatory, coercive unconsented and nonconfidential HIV testing for sex workers, periodic presumptive treatment for sexually transmitted diseases, and “strategic” programs for “key populations” are among the policies and practices discussed in this briefing paper that stand between people in vulnerable circumstances and the health services they need. The […]

As Ebola transmission in Guinea ends, Liberia counts down again, and a Public Health Emergency of International Concern continues

By on .

The last week of 2015 saw the pronouncement that Ebola transmission had ended in Guinea, the country where two years ago the spread of the virus that subsequently made itself felt around the world began. Guinea celebrated, as Liberia did first in May, and as Sierra Leone did best in November. The triumph this time, […]